Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Intellia Therapeutics Inc shares valued at $16,711 were sold by Dube Michael P on Jan 03 ’25. At $12.18 per share, Dube Michael P sold 1,372 shares. The insider’s holdings dropped to 45,640 shares worth approximately $0.46 million following the completion of this transaction.
Also, BASTA JAMES sold 7,074 shares, netting a total of over 86,161 in proceeds. Following the sale of shares at $12.18 each, the insider now holds 74,497 shares.
Before that, Lebwohl David had sold 9,557 shares from its account. In a trade valued at $116,404, the EVP, Chief Medical Officer traded Intellia Therapeutics Inc shares for $12.18 each. Upon closing the transaction, the insider’s holdings decreased to 9,557 shares, worth approximately $0.89 million.
As published in a research note from Morgan Stanley on January 27, 2025, Intellia Therapeutics Inc [NTLA] has been rated down from an Overweight to an Equal-weight and the price target has been revised to $11 from $56. Analysts at Goldman downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in late February. As of February 15, 2024, Wolfe Research has initiated its “Peer perform” rating for NTLA. Earlier on April 13, 2023, Canaccord Genuity initiated its rating. Their recommendation was “a Buy” for NTLA stock.
Analyzing NTLA Stock Performance
During the last five days, there has been a drop of approximately -8.08%. Over the course of the year, Intellia Therapeutics Inc shares have dropped approximately -13.21%. Shares of the company reached a 52-week high of $13.34 on 01/07/25 and a 52-week low of $9.25 on 01/16/25. A 50-day SMA is recorded $12.61, while a 200-day SMA reached $19.70. Nevertheless, trading volume fell to 2.53 million shares from 3.14 million shares the previous day.
Support And Resistance Levels for Intellia Therapeutics Inc (NTLA)
According to the 24-hour chart, there is a support level at 9.89, which, if violated, would cause prices to drop to 9.67. In the upper region, resistance lies at 10.38. The next price resistance is at 10.65. RSI (Relative Strength Index) is 38.87 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.10, which suggests the price will decrease in the coming days. Percent R is at 71.00%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
